Deals channel feed – Endpoints News

Deals channel feed

Following Vounatsos' announced departure, Biogen partners with private Canadian biotech for oral Parkinson's treatment

3 years ago

Following deep cuts, Yumanity strikes a deal to sell drugs to J&J, hands the keys to Genentech-partnered Kineta

3 years ago

Boehringer Ingelheim inks deal for targeted cancer antibodies from Singapore research org

3 years ago

Bristol Myers jumps into the M&A game with a $4B oncology buyout. And weary biotech analysts couldn't be any happier

3 years ago

Regeneron inks $1B+ deal for global rights to Sanofi-partnered PD-1 Libtayo

3 years ago

Immatics imagines broader CAR-T pipeline with another Bristol Myers pact and addition to 2019 TCR deal

3 years ago

Once a GSK hopeful for heart disease, an inhibitor class makes a comeback in Alzheimer's deal

3 years ago

Four years after Roche deal, little glyco-focused biotech lands new discovery deal with Astellas

3 years ago

Long after the blockbuster shoutouts faded to a whisper, TherapeuticsMD gets an M&A deal

3 years ago

GSK bets $3.3B on a buyout, jumping into a blockbuster showdown with Pfizer and Merck

3 years ago

After $60M Vertex deal, group of Catalyst shareholders claims biotech could’ve sold assets three years ago

3 years ago

Taking another shot at mRNA glory, CureVac inks oncology pact while keeping up with Covid work

3 years ago

Antios' HBV collab axed after clinical hold, but biotech believes safety incident is not treatment-related

3 years ago

Life sciences developer BioMed Realty buys San Francisco hotel for $75M — report

3 years ago

At the cusp of NDA filing for lead antibiotic, AstraZeneca spinout goes private at a fraction of IPO price

3 years ago

As GSK-partnered Covid antibody racks up global sales, Vir axes WuXi deal and grabs back China rights

3 years ago

Alcon takes a crack at multibillion-dollar dry eye market, picks up 2 drugs from Langer spinout

3 years ago

All Blue's $733M bid to acquire Zymeworks turns hostile as board battles back — after a biotech celebrity jumps in

3 years ago

Bayer sounds retreat from a $670 million CAR-T pact in the wake of a patient death

3 years ago

Pfizer teams up with digital therapeutics partner for next product launch, this time in atopic dermatitis

3 years ago

Resilience inks manufacturing pact with ARCH-backed cell therapy startup as it preps for the long haul

3 years ago

Bavarian Nordic secures BARDA contract for smallpox vaccine

3 years ago

Under-the-radar Chinese biotech scores $47M upfront in secretive Merck deal around cancer drug

3 years ago

An 'interestingly porous' pouch: Two startups team up on a potentially new way to treat diabetes

3 years ago

First page Previous page 57 58 596061 62 63 Next page Last page